Vulnerability in Gbgplc Acuant Acufill Sdk

CVE-2022-48222

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK installation, certutil.exe is called by the Acuant installer to install certificates. This window is not hidden, and is running with elevated privileges. A standard user can break out of this window, obtaining a full SYSTEM command prompt window. This results in complete compromise via arbitrary SYSTEM code execution (elevation of privileges).

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.001 (2.5th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 2nd percentile — 2.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2022-48222: held from 0.001 to 0.001.

EPSS over last 30 days · oldest: 0.001 · newest: 0.001 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2022-48222?
CVE-2022-48222 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk, classified under Uncontrolled Search Path Element. CVSS score: 7.8/10. Published 2023-04-04.
How severe is CVE-2022-48222?
High severity. CVSS v3 base score is 7.8 out of 10.